Skip to content

Public FDA record

Z-0438-03: PO2 electrode for Roche AVL OMNI Analyzers. Catalog number BP1734.

Recall record Z-0438-03 for Roche Diagnostics Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0438-03
Company in FDA record
Roche Diagnostics Corp.
FDA classification date
Jan 23, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Air bubbles trapped in the PO2 electrode will cause falsely elevated patient test results.

Source facts

Action
An urgent device correction letter dated 12/16/02 was sent to each customer. The letter advised of the problem and instructed customers to follow a strict quality control regime to ensure proper electrode performance. Customers were instructed how to automatically lock the affected parameter so that patient results will not be reported if QC performance violates the customer''s programmed rules.
Initiated
2002-12-16
Root cause
Other
Terminated
2003-03-19
Distribution
United States
Recall number
Z-0438-03
Recall status
Terminated
CDRH record ID
25329
FDA classified
2003-01-23
Recall event number
25169

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗